A systematic review of botulinum toxin as a treatment for raynaud’s disease secondary to scleroderma

HIGHLIGHTS

• What: The protocol for this review was registered on PROSPERO (CRD42023365143), and it is reported here following the Preferred Reporting Items for Systematic reviews and Metaanalysis (PRISMA) guidelines .
• Who: Calver Pang from the Department of Surgical Biotechnology, Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK have published the paper: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma, in the Journal: (JOURNAL) of 27/Nov/2023
• How: For this systematic review the authors selected outcomes commonly presenting in most . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.